Key points are not available for this paper at this time.
The COVID-19 pandemic has been a global public health problem. Latin America has had the highest mortality rates worldwide, with over 1.8 million deaths as of October 2023. Patients with end-stage renal disease have an increased risk of infection and mortality than the general population. Several national and international initiatives were created during the pandemic to support these patients, including obtaining relevant clinical data to potentiate public health initiatives. Our objective is to evaluate the impact of the SARS-CoV-2 pandemic in Latin America and to compare ESRD patients versus the general population in different countries.
Toro et al. (Mon,) studied this question.